title: The price of prevention: what now for immunisation against meningococcus B?
authors.affiliation: Department of Paediatrics, University of Oxford, Oxford OX3 7LE, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Moxon
authors.affiliation: Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Snape
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D008585:Meningitis, Meningococcal / Q000191:economics / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000191:economics*; D038541:Neisseria meningitidis, Serogroup B; D006113:United Kingdom; D014611:Vaccination / Q000191:economics
chemical_list: C570015:4CMenB vaccine; D022401:Meningococcal Vaccines